UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                              Washington, DC 20549


                                    FORM 8-K

             Current Report Pursuant to Section 13 or 15 (d) of the
                        Securities Exchange Act of 1934


Date of report (Date of earliest event reported):  October 25, 2004


                        Bio Solutions Manufacturing, Inc.
- -------------------------------------------------------------------------------
             (Exact Name of Registrant as Specified in its Charter)

                                    New York
          ------------------------------------------------------------
                 (State or Other Jurisdiction of Incorporation)


            000-33229                                        16-1576984
- ------------------------------------              ------------------------------
    (Commission File Number)                      (I.R.S. Employer
                                                           Identification No.)


                    1161 James Street, Hattiesburg, MS 39401
          ------------------------------------------------------------
               (Address of Principal Executive Offices) (Zip Code)


                                 (601) 582-4000
          ------------------------------------------------------------
              (Registrant's Telephone Number, Including Area Code)


          ------------------------------------------------------------
          (Former Name or Former Address, if Changed Since Last Report)



Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions:

[_]  Written  communications  pursuant to Rule 425 under the  Securities Act (17
     CFR 230.425

[_]  Soliciting  material  pursuant to Rule 14a-12  under the  Exchange  Act (17
     CFR240.14a-12)

[_]  Pre-commencement communications pursuant to Rule 14-2(b) under the Exchange
     Act (17 CFR 240.14d- 2(b))

[_]  Pre-commencement  communications  pursuant  to Rule  13(e)-4(c)  under  the
     Exchange Act (17 CFR 240.13e-4(c))


                                   Page 1 of 3





SECTION 1- REGISTRANT'S BUSINESS AND OPERATIONS

     Not Applicable


SECTION 2 - FINANCIAL INFORMATION

     Not Applicable


SECTION 3 - SECURITIES AND TRADING MARKETS

     Not Applicable


SECTION 4 - MATTERS RELATED TO ACCOUNTANTS AND FINANCIAL INFORMATION

     Not Applicable


SECTION 5 - CORPORATE GOVERNANCE AND MANAGEMENT

     Item 5.02 Departure of Principal Officer

     On  October  25,  2004,  the  Company   received   notice  of  and  thereby
subsequently  accepted the  resignation of Joe H. Ashley as  Secretary/Treasurer
and Chief Financial Officer.


SECTION 6 - [Reserved]

     Not Applicable


SECTION 7 - REGULATION FD

     Not Applicable


SECTION 8 - OTHER EVENTS

     Not Applicable





                                   Page 2 of 3





SECTION 9 - FINANCIAL STATEMENTS AND EXHIBITS

Exhibit         Description no.
- --------        -------------------------------------
17.1    *       Resignation of Principal Officer

- --------------

* Filed herewith



                                   SIGNATURES


     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.


                       Bio Solutions Manufacturing, Inc..
                                  (Registrant)


Date: October 25, 2004            By: /s/ Krish V. Reddy
     ---------------------            -----------------------------
                                      Krish V. Reddy, Ph.D.,
                                      President








                                   Page 3 of 3